| Code | CSB-MP004845HU |
| Abbreviation | Recombinant Human CCR6 protein-VLPs (Active) |
| MSDS | |
| Size | $558 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
CCR6 mediates the migration of dendritic cells and memory T cells to inflammatory sites through its interaction with CCL20, making it a target of interest in cancer immunology and autoimmune disease research. This full-length receptor (aa 1–374) is presented in virus-like particles produced in mammalian cells, a format that preserves native membrane topology and post-translational modifications critical for authentic ligand recognition. Functional ELISA validation demonstrates specific antibody binding with an EC50 of 44.79–56.10 ng/mL when the receptor is immobilized at 10 μg/mL, confirming that extracellular epitopes remain accessible and properly folded—a prerequisite for therapeutic antibody epitope mapping, competitive inhibition screening, and blocking antibody validation. With endotoxin levels below 1.0 EU/μg, this VLP-displayed receptor meets the quality thresholds commonly required for ligand-binding assays, SPR or BLI affinity characterization, and small-molecule inhibitor screening in drug discovery workflows targeting CCR6-CCL20 axis modulation.
There are currently no reviews for this product.